Thyroid C-cell warning: Rodent C-cell tumor findings underlie the labeled MTC/MEN-2 caution for approved GLP-1 drugs (human relevance uncertain), and it carries over to the semaglutide arm
Women with PMOS frequently face a frustrating choice between treatments that target reproductive symptoms and those that address metabolic health, says Melanie Cree, MD, PhD, professor at CU Anschutz and first author of the report
Semaglutide Treatment Book Your Free 15 Minute Consultation
Some are navigating cost or insurance changes, while others are dealing with side effects
Your physician may increase your dose as needed
Gallbladder problems, severe stomach problems, or diabetic retinopathy (vision changes) have also been reported